ISPOR 17th Annual International Meeting
June 2-6, 2012, Washington, DC, USA
Search:
Value-based Decision Making in Rheumatic Disease : What does it mean for pharmacists ?
Médicaments Issus des Biotechnologies : Différencier Les Prix selon la Valeur
Comments on : Performance-Based Risk-Sharing Arrangements - Good practice for design, implementation and evaluation. An ISPOR Task force review
EUnetHTA : Draft Guidelines - Endpoints used for REA of pharmaceuticals HEALTH-RELATED QUALITY OF LIFE and UTILITY MEASURES
Home
Selected articles
EUNetHTA
Pazopanib for the treatment of advanced renal cell carcinoma
June, 2nd, 2012
(
PDF, 1.1 Mo
)
(
Word, 76.5 ko
)
Value-based Decision Making in Rheumatic Disease : What does it mean for pharmacists ?
